MyPath Melanoma

Learn about Castle’s comprehensive diagnostic offering

Our suite of objective and highly accurate tests for melanocytic lesions of uncertain potential increases diagnostic confidence and enables better clinical management plans for patients. Learn the essentials from this comprehensive introduction by Matthew Goldberg, MD, Senior Vice President, Medical for Castle Biosciences.